iRadimed Corporation is a medical device company that develops, manufactures, markets, and distributes MRI-compatible patient care solutions. Its product portfolio includes MRI-compatible intravenous infusion pump systems, patient vital signs monitoring systems, ferromagnetic detection devices, and related accessories and disposables designed for use in magnetic resonance imaging environments. The company’s products are used by hospitals, acute care facilities, and outpatient imaging centers to support patient monitoring and medication delivery during MRI procedures. iRadimed Corporation focuses on equipment engineered with non-magnetic components to help maintain clinical workflow and patient safety in high-field imaging settings. Headquartered in Orlando, Florida, iRadimed Corporation serves customers in the United States and internationally through a specialized medical technology platform centered on MRI-compatible care.
Website12705 Ingenuity Drive
Orlando, FL, 32826
United States
What share of all stock conversation is about IRMD?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% 0 | 0% 0 | 0% +0 |
Of the messages about IRMD that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | — | 70% -30 | ||
| Bearish | — | — | — | 30% new |
Of the messages about IRMD that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | — | — | 9.38% | ||
| Earnings | — | — | — | 9.38% | ||
| Analysts | — | — | — | 34.38% | ||
| Controversies | — | — | — | 0% | ||
| Macro | — | — | — | 0% | ||
| Technical Analysis | — | — | — | 46.88% |
Of the messages about IRMD, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | — | 100% | 9.58% | ||
| Newcomers | — | — | 0% | 90.42% |
iRadimed Corp (IRMD) navigates a pivotal transition quarter with robust bookings for its next-generation MRI pump, offset by near-term margin pressure and flat revenue growth.
Moby summary of IRadimed Corporation's Q2 2026 earnings call
Investors talking about IRMD also mention